Vitamin D in Diabetic Neuropathy | MicrobiomeTrials← Back to trialsNCT07644520
Vitamin D in Diabetic Neuropathy
RecruitingPHASE2, PHASE3INTERVENTIONAL
Trial Details
Start: 2026-10-01Est. Completion: 2027-10-01
Enrollment target: 150 participants Other microbiome trials you might be interested in
Diabetes Mellitus, Type 2
Empagliflozin, a sodium glucose co-transporter 2 (SGLT-2) inhibitor, was launched as a treatment for type 2 diabetes mel…
Boston, United StatesEst. completion Jun 30, 2026
Diabetes Mellitus, Type 2Liver DiseasesKidney DiseasesLung DiseasesMetabolic DiseasesHealthy Volunteers
This is a prospective, multicentric, non-treatment study to build and validate a portable, non-invasive smart breath ana…
Mysore, IndiaCompleted Oct 3, 2023